Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biocorrx Inc (BICX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 22,259
  • Shares Outstanding, K 255,850
  • Annual Sales, $ 660 K
  • Annual Income, $ -29,710 K
  • 36-Month Beta 1.04
  • Price/Sales 46.47
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/13/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0500 +78.00%
on 12/31/18
0.0900 -1.11%
on 01/18/19
+0.0170 (+23.61%)
since 12/18/18
3-Month
0.0410 +117.07%
on 11/19/18
0.0910 -2.20%
on 10/19/18
-0.0004 (-0.45%)
since 10/18/18
52-Week
0.0410 +117.07%
on 11/19/18
0.2820 -68.44%
on 01/26/18
-0.1260 (-58.60%)
since 01/18/18

Most Recent Stories

More News
Brady Granier, CEO, President, and Director of BioCorRx Inc. Provides Update and Outlook in a New Audio Interview with SmallCapVoice.com

SmallCapVoice.com, Inc. (SCV) and BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of substance use disorders, announced today that a new audio...

BICX : 0.0890 (+2.30%)
BioCorRx Provides Business Update for the Third Quarter of 2018

via NEWMEDIAWIRE - BioCorRx, Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of substance use disorders, today provided a business update for the third...

BICX : 0.0890 (+2.30%)
BioCorRx Inc.'s CEO Talks NIDA Grant Update and a Promising New Product with Uptick Newswire's Stock Day Podcast

BioCorRx Inc. (OTCQB: BICX) (the "Company") is a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions. President, CEO, and Director of BioCorRx Inc, Brady Granier...

BICX : 0.0890 (+2.30%)
BioCorRx, Inc. Announces Preliminary Agreement with VDM Biochemicals to Develop and Commercialize Patented Opioid Antagonist VDM-001

EQNX::TICKER_START (Other OTC:BICX),(OTC Markets:BICX), EQNX::TICKER_END

BICX : 0.0890 (+2.30%)
BioCorRx Provides BICX102 Grant Update

via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of substance use disorders, today provided an update on the grant submitted...

BICX : 0.0890 (+2.30%)
BioCorRx CEO Brady Granier Discusses BioCorRx Recovery Program on This Life #YouLive Podcast Hosted by Dr. Drew

via NEWMEDIAWIRE-- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady Granier, BioCorRx...

BICX : 0.0890 (+2.30%)
BioCorRx to Exhibit at the 2nd Annual National Opioid Crisis Management Congress

via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that the Company will...

BICX : 0.0890 (+2.30%)
BioCorRx Gains Additional Media Coverage from Fox Medical Correspondent Who Discusses the Advantages of the Naltrexone Implant

BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today reported that Dr. Mark Siegel, commented on the advantages...

BICX : 0.0890 (+2.30%)
BioCorRx CEO Brady Granier and Legendary Soul Man Sam Moore Appear on Fox Business Network to Discuss the Company's Naltrexone Implant, Which Helps Combat Opioid Addiction

BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady Granier, BioCorRx CEO, President,...

BICX : 0.0890 (+2.30%)
BioCorRx Provides Business Update for the Full Year Ended 2017

BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today provided a business update for the year ended December...

BICX : 0.0890 (+2.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade BICX with:

Key Turning Points

2nd Resistance Point 0.1095
1st Resistance Point 0.0992
Last Price 0.0890
1st Support Level 0.0695
2nd Support Level 0.0501

See More

52-Week High 0.2820
Fibonacci 61.8% 0.1899
Fibonacci 50% 0.1615
Fibonacci 38.2% 0.1331
Last Price 0.0890
52-Week Low 0.0410

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar